| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |